These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 26384362)

  • 21. Adult-onset autoimmune diabetes identified by glutamic acid decarboxylase autoantibodies: a retrospective cohort study.
    Wada E; Onoue T; Kinoshita T; Hayase A; Handa T; Ito M; Furukawa M; Okuji T; Kobayashi T; Iwama S; Sugiyama M; Takagi H; Hagiwara D; Suga H; Banno R; Goto M; Arima H
    Diabetologia; 2021 Oct; 64(10):2183-2192. PubMed ID: 34268631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sensitive non-isotopic assays for autoantibodies to IA-2 and to a combination of both IA-2 and GAD65.
    Chen S; Willis J; Maclean C; Ananieva-Jordanova R; Amoroso MA; Brooking H; Powell M; Collins A; Bennett S; Mitchell S; Burne P; Furmaniak J; Smith BR
    Clin Chim Acta; 2005 Jul; 357(1):74-83. PubMed ID: 15963796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of serum and EDTA plasma in the measurement of glutamic acid decarboxylase autoantibodies (GADA) and autoantibodies to islet antigen-2 (IA-2A) using the RSR radioimmunoassay (RIA) and enzyme linked immunosorbent assay (ELISA) kits.
    Rahmati K; Lernmark A; Becker C; Foltyn-Zadura A; Larsson K; Ivarsson SA; Törn C
    Clin Lab; 2008; 54(7-8):227-35. PubMed ID: 18942490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diagnostic value of serum islet autoantibody in hepatogenic diabetes mellitus].
    Zhang L; Shi YL; Hong WX; Jia WD; Li LH
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jul; 26(7):1034-6. PubMed ID: 16864107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glutamic acid decarboxylase autoantibodies in saliva of children with type 1 diabetes.
    Markopoulos AK; Belazi MA; Drakoulakos D
    Diabetes Res Clin Pract; 1997 Dec; 38(3):169-72. PubMed ID: 9483382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of 2 alternative enzyme-linked immunosorbent assays for routine screening of glutamic acid decarboxylase autoantibodies.
    Villalba A; Valdez SN; Iacono RF; Poskus E
    Clin Chim Acta; 2007 Feb; 376(1-2):82-7. PubMed ID: 16963012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Slowly progressive insulin-dependent (type 1) diabetes positive for anti-GAD antibody ELISA test may be strongly associated with a future insulin-dependent state.
    Oikawa Y; Tanaka H; Uchida J; Atsumi Y; Osawa M; Katsuki T; Kawai T; Shimada A
    Endocr J; 2017 Feb; 64(2):163-170. PubMed ID: 27760891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of glutamic acid decarboxylase autoantibodies with the varelisa ELISA.
    Gronowski AM; Wong EC; Wilhite TR; Martin DL; Smith CH; Parvin CA; Landt M
    Clin Chem; 1995 Oct; 41(10):1532-4. PubMed ID: 7586530
    [No Abstract]   [Full Text] [Related]  

  • 29. Unique epitopes of glutamic acid decarboxylase autoantibodies in slowly progressive type 1 diabetes.
    Kobayashi T; Tanaka S; Okubo M; Nakanishi K; Murase T; Lernmark A
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4768-75. PubMed ID: 14557453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of glutamic acid decarboxylase 65 (GAD65) autoantibody assay using biotin-GAD65 fusion protein.
    Luo D; Rogers CN; Steed JT; Gilliam LK; Hampe CS; Lernmark A
    J Biotechnol; 2004 Jul; 111(1):97-104. PubMed ID: 15196774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation of a rapid type 1 diabetes autoantibody screening assay for community-based screening of organ donors to identify subjects at increased risk for the disease.
    Wasserfall C; Montgomery E; Yu L; Michels A; Gianani R; Pugliese A; Nierras C; Kaddis JS; Schatz DA; Bonifacio E; Atkinson MA
    Clin Exp Immunol; 2016 Jul; 185(1):33-41. PubMed ID: 27029857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A decrease in glutamic acid decarboxylase autoantibody levels with sitagliptin use in patients with latent autoimmune diabetes in adults.
    Yanai H
    Diabetes Metab; 2018 Mar; 44(2):188-189. PubMed ID: 28571922
    [No Abstract]   [Full Text] [Related]  

  • 33. Autoantibodies to glutamate decarboxylase detected in diabetes-prone BB/OK rats do not distinguish onset of diabetes.
    Ziegler M; Schlosser M; Hamann J; Vieregge P; Lühder F; Klöting I; Ziegler B
    Exp Clin Endocrinol; 1994; 102(2):98-103. PubMed ID: 8056059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glutamic acid decarboxylase autoantibody prevalence and association with HLA genotype in patients with younger-onset type 1 diabetes and proliferative diabetic retinopathy.
    Mimura T; Funatsu H; Uchigata Y; Kitano S; Shimizu E; Amano S; Yamagami S; Noma H; Araie M; Hori S
    Ophthalmology; 2005 Nov; 112(11):1904-9. PubMed ID: 16157380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparing the clinical significance and antigen specificity of insulinoma-associated antigen-2 autoantibodies between radioimmunoassay and enzyme-linked immunosorbent assay in Japanese patients with type 1 diabetes.
    Kawasaki E; Shimada A; Imagawa A; Abiru N; Awata T; Oikawa Y; Osawa H; Kawabata Y; Kozawa J; Kobayashi T; Takahashi K; Chujo D; Fukui T; Miura J; Yasuda K; Yasuda H; Kajio H; Hanafusa T; Ikegami H;
    J Diabetes Investig; 2023 Jan; 14(1):58-66. PubMed ID: 36177861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glutamic acid decarboxylase 65 autoantibody levels discriminate two subtypes of latent autoimmune diabetes in adults.
    Li X; Yang L; Zhou Z; Huang G; Yan X
    Chin Med J (Engl); 2003 Nov; 116(11):1728-32. PubMed ID: 14642146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Persisting antibodies to glutamic acid decarboxylase in type 1 (insulin-dependent) diabetes mellitus are not associated with neuropathy.
    Tuomi T; Zimmet PZ; Rowley MJ; Serjeantson SW; Mackay IR
    Diabetologia; 1993 Jul; 36(7):685. PubMed ID: 8359590
    [No Abstract]   [Full Text] [Related]  

  • 38. Characterization of hydroxyl radical modified GAD65: a potential autoantigen in type 1 diabetes.
    Khan MW; Sherwani S; Khan WA; Ali R
    Autoimmunity; 2009 Feb; 42(2):150-8. PubMed ID: 19085183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Absence of avidity maturation of autoantibodies to the protein tyrosine phosphatase-like IA-2 molecule and glutamic acid decarboxylase (GAD65) during progression to type 1 diabetes.
    Westerlund A; Ankelo M; Ilonen J; Knip M; Simell O; Hinkkanen AE
    J Autoimmun; 2005 Mar; 24(2):153-67. PubMed ID: 15829408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Value of glutamic acid decarboxylase autoantibody detection for early diagnosis of latent autoimmune diabetes in adults].
    Huang YY; Huang P; Lou HL
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Aug; 23(8):868-9. PubMed ID: 12919925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.